ArticleMolecular therapy. Nucleic acids2025

Nose-to-brain siRNA delivery by PEI/PPI-based nanoparticles reduces α-synuclein expression in a Parkinson's disease mouse model.

Malte Feja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.